Oath Peptides Ratings Methodology v1 / 2026.05
Issued 2026.05

EDITORIAL CONTACT

Contact Oath Peptides Ratings.

Editorial inquiries, correction requests, and methodology questions about the four-category scored rubric.

What this form is for

This contact form routes to the editorial inbox for Oath Peptides Ratings — the four-category scored-rubric site you have been reading. Use it for:

  • Correction requests. If a quantitative claim on any page is inconsistent with the cited source, or a cited URL has moved or broken, we want to know. Include the page slug and the specific claim.
  • Methodology questions. If a rubric input or weight is unclear, or if you want to know why a specific evidence source was weighted as it was, we will explain.
  • Editorial inquiries. If you are a publication interested in citing the methodology, or an independent researcher with a methodology question, we will respond.

This form is not for contacting Oath Peptides directly. We are not affiliated with the company we review and we cannot process customer-service inquiries, refund requests, product questions, or shipping inquiries on the company's behalf. To reach Oath Peptides directly, use the contact channels listed on the brand site.

Editorial contact form

This form opens your default email client. No tracking, no marketing list, no commercial follow-up — this is a publication contact form, not a lead-capture form.

Editorial standards on corrections

If we issue a correction in response to a verified inconsistency, the correction appears in-line at the relevant page section with a brief disclosure of what was corrected and when. We do not silently edit; we mark corrections so readers can see what changed. If the correction affects a category score or the composite, we update the relevant rubric inputs and the composite letter grade and disclose the change on the methodology page in a methodology-version note.

We respond to good-faith correction requests. We do not respond to threats, demands to remove non-actionable editorial commentary, or commercial inquiries from peptide vendors or vendor-scoring services. Editorial commentary on publicly available information is what this site is for.